Device therapies among patients receiving primary prevention implantable cardioverter‐defibrillators in the Cardiovascular research network

RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - Am Heart Assoc
Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverterâ Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - 2018 - deepblue.lib.umich.edu
Background-—Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

[HTML][HTML] Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - ncbi.nlm.nih.gov
Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - J Am Heart …, 2018 - scholarlycommons.henryford.com
BACKGROUND: Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.

RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - europepmc.org
Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - Journal of the …, 2018 - touroscholar.touro.edu
BACKGROUND: Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, JH Gurwitz, DD McManus - 2018 - repository.escholarship.umassmed …
BACKGROUND: Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

[PDF][PDF] Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - 2018 - pdfs.semanticscholar.org
Background-—Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

[PDF][PDF] Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network

RT Greenlee, AS Go, PN Peterson… - 2018 - academia.edu
Background-—Primary prevention implantable cardioverter-defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …